Rutgers Helps Clinical Trial on ‘Chemo Brain’ Enrol Breast Cancer Patients

Rutgers Helps Clinical Trial on ‘Chemo Brain’ Enrol Breast Cancer Patients
shutterstock_118491940 Breast cancer patients at Rutgers Cancer Institute are actively being referred to an ongoing clinical trial that seeks to understand the effects of hormonal therapy and chemotherapy on the brain - manifestations dubbed informally as "Chemo Brain". The study is being conducted by the Kessler Foundation together with the Cancer Institute of New Jersey, and is funded by the National Institutes of Health. Oftentimes, when breast cancer patients go through any or both of these forms of treatment, they develop side effects that can make concentrating, remembering, and tasks that require intensive hand movement unusually difficult. While these are not life-threatening, they can seriously affect patients' quality of life. The study is attempting to understand these effects, thought to be caused by cancer medication, by examining neurologic changes within breast cancer patients' brains. Dr. Serena Wong, a medical oncologist at the Cancer Institute and an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, serves as the study's referring physician and leads the screening process f
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.